(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SPIROXIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SPIROXIS

ST13

US500000079327764

Class

5

Filing

79327764

Registration

7021174

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

02/14/2026

Trademark type

Word

Nice classes

5

Filing date

11/03/2021

Registration date

04/11/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/11/2023

Last transaction

02/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

SE

Examiner

GANESH, HARINI

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vicore Pharma AB

Representatives

Sarah J. Schneider Sheridan Ross P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals and medical preparations for human useprescription drugspillstabletscapsulescapletsliquid drops sachets for the treatment of pulmonary diseasescardiovascular diseasesautoimmune and inflammatory diseasesfibrotic diseases and kidney diseases; pharmaceutical preparations for use within the fields of pulmonary diseasescardiovascular diseasesautoimmune and inflammatory diseasesfibrotic diseases and kidney diseases; pharmaceutical preparations for treating and preventing pulmonary fibrosisidiopathic pulmonary fibrosis; pharmaceutical preparations for use in treating diffuse systemic sclerosis with lung manifestations; pharmaceutical preparations for treating infectious lung diseases; pharmaceutical preparations for treatment and prevention of covid-19

Publications

History of USPTO decisions and trademark events.

28 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/12/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/22/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/14/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/26/2023

FIMP

FINAL DISPOSITION PROCESSED

07/26/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/11/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/11/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

04/11/2023

GPNX

NOTIFICATION PROCESSED BY IB

01/24/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/24/2023

PUBO

PUBLISHED FOR OPPOSITION

01/24/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/04/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/04/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/04/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/21/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/20/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/20/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/20/2022

RFNT

REFUSAL PROCESSED BY IB

07/26/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/01/2022

RFRR

REFUSAL PROCESSED BY MPU

07/01/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/29/2022

CNRT

NON-FINAL ACTION WRITTEN

06/28/2022

DOCK

ASSIGNED TO EXAMINER

06/22/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/21/2022

MAFR

APPLICATION FILING RECEIPT MAILED

12/14/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/10/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/09/2021

Continuous trademark protection

Get notified about every new filing that threatens SPIROXIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.